S100A8 Antibody
Shipped with Ice Packs 
In Stock 
Product Specs
Buffer
PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. Store at -20°C. Avoid freeze/thaw cycles.
Form
Liquid
Lead Time
Typically, we can ship products within 1-3 business days after receiving your order. Delivery time may vary depending on the purchasing method or location. Please consult your local distributors for specific delivery timelines.
Synonyms
60B8Ag antibody; AI323541 antibody; B8Ag antibody; BEE11 antibody; CAGA antibody; Calgranulin-A antibody; Calprotectin L1L subunit antibody; Calprotectin; included antibody; CFAG antibody; CGLA antibody; Chemotactic cytokine CP-10 antibody; CP-10 antibody; Cystic fibrosis antigen antibody; L1Ag antibody; Leukocyte L1 complex light chain antibody; MA387 antibody; MIF antibody; Migration inhibitory factor-related protein 8 antibody; MRP-8 antibody; Myeloid-related protein 8 antibody; Neutrophil cytosolic 7 kDa protein antibody; NIF antibody; p8 antibody; Pro-inflammatory S100 cytokine antibody; Protein S100-A8 antibody; S100 calcium binding protein A8 (calgranulin A) antibody; S100 calcium binding protein A8 antibody; S100 calcium-binding protein A8 antibody; S100A8 antibody; S100A8/S100A9 complex; included antibody; S10A8_HUMAN antibody; Urinary stone protein band A antibody
Target Names
Uniprot No.
Target Background
Function
S100A8 is a calcium- and zinc-binding protein that plays a significant role in regulating inflammatory processes and immune responses. It can induce neutrophil chemotaxis and adhesion. Primarily found as calprotectin (S100A8/A9), it exhibits a wide range of intra- and extracellular functions.
Intracellular functions include: facilitating leukocyte arachidonic acid trafficking and metabolism, modulating the tubulin-dependent cytoskeleton during phagocyte migration, and activating neutrophilic NADPH-oxidase. S100A8 activates NADPH-oxidase by facilitating the enzyme complex assembly at the cell membrane, transferring arachidonic acid (an essential cofactor) to the enzyme complex, and directly binding to NCF2/P67PHOX, contributing to enzyme assembly.
Extracellular functions encompass proinflammatory, antimicrobial, oxidant-scavenging, and apoptosis-inducing activities. Its proinflammatory activity involves leukocyte recruitment, promotion of cytokine and chemokine production, and regulation of leukocyte adhesion and migration. S100A8 acts as an alarmin or a danger-associated molecular pattern (DAMP) molecule, stimulating innate immune cells by binding to pattern recognition receptors such as Toll-like receptor 4 (TLR4) and receptor for advanced glycation endproducts (AGER). Binding to TLR4 and AGER activates the MAP-kinase and NF-kappa-B signaling pathways, amplifying the proinflammatory cascade.
S100A8 exhibits antimicrobial activity against bacteria and fungi, likely through chelation of Zn(2+), an essential nutrient for microbial growth. It can induce cell death via autophagy and apoptosis, involving cross-talk between mitochondria and lysosomes via reactive oxygen species (ROS), and the process includes BNIP3. S100A8 regulates neutrophil number and apoptosis by an anti-apoptotic effect, influencing cell survival through ITGAM/ITGB and TLR4 via a signaling mechanism involving MEK-ERK.
Its role as an oxidant scavenger provides protection by preventing excessive tissue damage through the removal of oxidants. S100A8 can act as a potent amplifier of inflammation in autoimmune disorders and cancer development and spread. The iNOS-S100A8/A9 transnitrosylase complex directs selective inflammatory stimulus-dependent S-nitrosylation of GAPDH and potentially multiple targets such as ANXA5, EZR, MSN, and VIM by recognizing a [IL]-x-C-x-x-[DE] motif. S100A8 appears to contribute to S-nitrosylation site selectivity.
Upon infection by human coronavirus SARS-CoV-2, S100A8 may induce the expansion of aberrant immature neutrophils in a TLR4-dependent manner.
Intracellular functions include: facilitating leukocyte arachidonic acid trafficking and metabolism, modulating the tubulin-dependent cytoskeleton during phagocyte migration, and activating neutrophilic NADPH-oxidase. S100A8 activates NADPH-oxidase by facilitating the enzyme complex assembly at the cell membrane, transferring arachidonic acid (an essential cofactor) to the enzyme complex, and directly binding to NCF2/P67PHOX, contributing to enzyme assembly.
Extracellular functions encompass proinflammatory, antimicrobial, oxidant-scavenging, and apoptosis-inducing activities. Its proinflammatory activity involves leukocyte recruitment, promotion of cytokine and chemokine production, and regulation of leukocyte adhesion and migration. S100A8 acts as an alarmin or a danger-associated molecular pattern (DAMP) molecule, stimulating innate immune cells by binding to pattern recognition receptors such as Toll-like receptor 4 (TLR4) and receptor for advanced glycation endproducts (AGER). Binding to TLR4 and AGER activates the MAP-kinase and NF-kappa-B signaling pathways, amplifying the proinflammatory cascade.
S100A8 exhibits antimicrobial activity against bacteria and fungi, likely through chelation of Zn(2+), an essential nutrient for microbial growth. It can induce cell death via autophagy and apoptosis, involving cross-talk between mitochondria and lysosomes via reactive oxygen species (ROS), and the process includes BNIP3. S100A8 regulates neutrophil number and apoptosis by an anti-apoptotic effect, influencing cell survival through ITGAM/ITGB and TLR4 via a signaling mechanism involving MEK-ERK.
Its role as an oxidant scavenger provides protection by preventing excessive tissue damage through the removal of oxidants. S100A8 can act as a potent amplifier of inflammation in autoimmune disorders and cancer development and spread. The iNOS-S100A8/A9 transnitrosylase complex directs selective inflammatory stimulus-dependent S-nitrosylation of GAPDH and potentially multiple targets such as ANXA5, EZR, MSN, and VIM by recognizing a [IL]-x-C-x-x-[DE] motif. S100A8 appears to contribute to S-nitrosylation site selectivity.
Upon infection by human coronavirus SARS-CoV-2, S100A8 may induce the expansion of aberrant immature neutrophils in a TLR4-dependent manner.
Gene References Into Functions
- A study found that co-stimulation with both advanced glycation end-products and Porphyromonas gingivalis LPS increased S100A8 and S100A9 mRNA expression in gingival epithelial cells. These findings demonstrate that the upregulation of calprotectin in gingival epithelial cells primarily functions intracellularly in this tissue and may contribute to the pathogenesis of periodontitis. PMID: 28771806
- Our results showed that S100A8/A9, absent or present at very low levels in skin biopsies from healthy subjects, is dramatically upregulated in each epidermal layer from psoriatic patients. PMID: 29605872
- The results suggest that the calcium-binding proteins S100A8 and S100A9 in myeloid cells have an immune regulatory effect. PMID: 29933628
- Median MRP8/14 levels were higher in patients with Takayasu arteritis. PMID: 29196802
- S100A8 gene knockdown reduced cell proliferation in HEC-1A cells compared to control cells, induced cell apoptosis, inhibited the phosphorylation of protein kinase B (Akt), and induced the expression of pro-apoptotic genes. PMID: 29595187
- Wide intra- and interindividual differences in calprotectin concentrations in the meconium may reflect intestinal inflammation associated with fetal adaptation to life outside the uterus. PMID: 28463850
- Salivary calprotectin levels were significantly higher in the RAS [Recurrent aphthous stomatitis] group (23.72 +/- 4.28 mg/L) compared to the HC [Healthy Controls] (21.59 +/- 4.27 mg/L) (P = 0.013). No significant relationship was found between calprotectin levels and age or gender in both groups (P >0.05). PMID: 29519972
- The levels of S100A8 and S100A9 in the sera, and calprotectin levels in the sera and urines of bladder cancer patients, were determined. PMID: 28609200
- MRP-8/14 concentration increases in coronary artery blood in association with thrombus formation in acute coronary syndrome. PMID: 28986057
- ANGPTL6, S100A8, and S100A9 are overexpressed in the skin of psoriasis patients versus zero expression in controls. PMID: 27698489
- Elevated breast cancer cell and stromal S100A8 protein expression are significant indicators of poorer outcomes in early-stage breast cancer patients. Evaluation of S100A8 protein expression may provide additional prognostic information beyond traditional breast cancer prognostic biomarkers. PMID: 28717852
- S100A8 was required for laser-induced new collagen synthesis in skin cells. PMID: 29270708
- S100A8 methylation plays a role in the diagnosis and prognosis of hepatocellular carcinoma. PMID: 27462864
- This study demonstrated that S100A8 was detected in the serums of Alzheimer's disease patients. PMID: 27911324
- Studies indicate S100A8 as the most overexpressed gene, and the cell cycle pathway as the most promising biomarker and therapeutic target for relapsed childhood B-acute lymphoblastic leukemia (B-ALL). PMID: 28183295
- Low S100A8 expression is associated with head and neck neoplasms. PMID: 26883112
- Report role of fecal calprotectin assay in the diagnosis and management of inflammatory bowel disease. PMID: 28735301
- S100A8 and S100A9 aggravate Coxsackievirus B3-induced myocarditis and might serve as therapeutic targets in inflammatory cardiomyopathies. PMID: 29158436
- Data suggest that fecal calprotectin may be a potential biomarker to identify patients with ankylosing spondylitis (AS) at risk of developing inflammatory bowel disease (IBD). PMID: 28148281
- Elevated S100A8 and S100A9 gene expression in SP-infected HMEECs and in the middle ear mucosa of OM, minor co-localized with neutrophil markers, suggests that middle ear epithelial cell secretion of S100A8 and S100A9 may play a role in the pathogenesis of recurrent and chronic OM. PMID: 28964306
- The results of this study support an additional role of calprotectin in assessing inflammatory activity in patients with RA. PMID: 28832684
- Data show that E3 ubiquitin ligase HRD1 (HRD1) decreased the protein level of S100A8 through ubiquitination. PMID: 28423597
- High S100A8 expression is associated with glioblastoma. PMID: 27006175
- This study implicates S100A8 and S100A9 as important mediators of tumor cell aggressiveness, and highlights the therapeutic potential of S100A8 and S100A9 for interference with metastasis. PMID: 27086923
- Data indicate a statistical correlation between fecal calprotectin (FC) and gastrointestinal graft-versus-host disease (GvHD). PMID: 28293713
- Perinatal alarmins S100A8 and S100A9 specifically altered MyD88-dependent proinflammatory gene programs. S100 programming prevented hyperinflammatory responses without impairing pathogen defense. TRIF-adaptor-dependent regulatory genes remained unaffected by perinatal S100 programming and responded strongly to lipopolysaccharide, but were barely expressed. PMID: 28459433
- Expression of S100A8, S100A9, and S100A12 is modulated by eicosapentaenoic acid and docosahexaenoic acid during inflammation in adipose tissue and mononuclear cells. PMID: 28125622
- High S100A8 expression is associated with lung metastasis in malignant melanoma. PMID: 27151304
- Data show that the standardized nerve growth factor (NGF) concentration was negatively correlated with continuous pain, neuropathic pain, and total score, and the standardized S100 proteins S100A8/A9 concentration was positively correlated with present pain intensity and continuous pain. PMID: 27936243
- S100A8 and S100A9 proteins in concentrations secreted by CD34(-)/CD31(+) circulating angiogenic cells (CACs) with impaired function reduce endothelial cell capillary-like network formation. These effects appear to be mediated by Toll-like receptor 4 and are absent with S100A8 and S100A9 in concentrations secreted by healthy CD34(-)/CD31(+) CACs. PMID: 27793853
- MRP8 elevated serum levels in patients with Behcet's disease indicate MRP8's role in the pathogenetic mechanisms of Behcet's disease. PMID: 25471894
- High baseline serum MRP8/14 levels are associated with lower survival in Chinese peritoneal dialysis patients. PMID: 22699162
- In acute coronary syndromes, MRP8 and MRP8/14 complex are specific ligands of TLR4, which induce the release of TNFalpha and probably other pro-inflammatory agents from monocytes. PMID: 21782178
- A study revealed a novel role of MRP8/14 in the autophagy-mediated elimination of intracellular BCG by promoting reactive oxygen species generation. PMID: 25312864
- MRP8 has a crucial role in stimulating IL-6 expression by rheumatoid arthritis fibroblast-like synoviocytes. PMID: 23619188
- Decreased pretreatment levels of myeloid-related protein-8/14 and C-reactive protein may have a role in poor adherence to treatment with tumor necrosis factor inhibitors in juvenile idiopathic arthritis. PMID: 27562034
- MRP8/14 can activate cells by binding to TLR4, leading to the release of proinflammatory cytokines. These mediators can lead to increased disease activity in enthesitis-related arthritis. PMID: 24231443
- Fibronectin adhesive capacity and integrin expression of monocytes of type 1 and type 2 diabetic patients are related to the subjects' serum levels of MRP-8. PMID: 15277376
- Excessive release of cytotoxic MRP8/MRP14 by activated phagocytes might therefore present an important molecular pathomechanism contributing to endothelial damage during vasculitis and other inflammatory diseases. PMID: 17095618
- MRP8 expression is related to the pathological stage of laryngeal squamous cell carcinoma. PMID: 22256739
- MRP8/14 in ankylosing spondylitis is associated with peripheral arthritis and active disease. PMID: 27738838
- Circulating MRP-8/14 is associated with TX-dependent platelet activation in ACS, even during low-dose aspirin treatment, suggesting a contribution of residual TX to MRP-8/14 shedding, which may further amplify platelet activation. PMID: 25037196
- Phosphorylation inhibits tubulin polymerization in microtubules. PMID: 15331440
- Data suggest that tissue infiltrating macrophages secreting MRP8/14 may contribute to myositis, by driving the local production of cytokines directly from muscle. PMID: 24286299
- Calprotectin induces IL-6 and MCP-1 production in Human Gingival Fibroblasts via TLR4 signaling that involves MAPK and NF-kappaB, resulting in the progression of periodontitis. PMID: 27925202
- Findings suggest that S100A8/A9 may be involved in the inflammatory response with induction of proinflammatory cytokines and may serve as a clinicopathological marker for disease activity in AOSD. PMID: 27537874
- Peripheral blood levels of S100A8 and TRAF6 in SAE patients were elevated and might be related to the severity of SAE and predict the outcome of SAE. PMID: 27411454
- Low S100A8/A9 levels may contribute to poor wound healing in colonized chronic wounds with a striking difference between diabetic foot ulcers and venous leg ulcers. PMID: 27084691
- Suggest that, in individuals with lichen planus, S100A8 may exert distinct immunomodulatory and cytotoxicity functions. PMID: 26632637
- Serum calprotectin was significantly higher in rheumatoid arthritis patients than controls, and was correlated with disease activity. It was higher in seropositive than in seronegative patients. PMID: 26767827
Database Links
Protein Families
S-100 family
Subcellular Location
Secreted. Cytoplasm. Cytoplasm, cytoskeleton. Cell membrane; Peripheral membrane protein. Note=Predominantly localized in the cytoplasm. Upon elevation of the intracellular calcium level, translocated from the cytoplasm to the cytoskeleton and the cell membrane. Upon neutrophil activation or endothelial adhesion of monocytes, is secreted via a microtubule-mediated, alternative pathway.
Tissue Specificity
Calprotectin (S100A8/9) is predominantly expressed in myeloid cells. Except for inflammatory conditions, the expression is restricted to a specific stage of myeloid differentiation since both proteins are expressed in circulating neutrophils and monocytes
Quick Inquiry
Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
